Overview
- Legal name
- LUMOS DIAGNOSTICS, INC
- Registered location
- CARLSBAD, CA, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 27, 2025
Read company summary
LUMOS DIAGNOSTICS, INC is associated with UEI CRKMAE3F8ZJ1 and CAGE 82T59 in public federal records. AcornBids currently links 1 prime award totaling $9.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists CARLSBAD, CA, USA.
At a glance
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 8, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- LUMOS DIAGNOSTICS, INC
- UEI
- CRKMAE3F8ZJ1
- CAGE
- 82T59
- Registered address
- 2724 LOKER AVE W, CARLSBAD, CA, 92010, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jul 31, 2026
- Initial registration
- Mar 26, 2018
- Entity start
- May 30, 2017
- SAM updated
- Jul 31, 2026
- Registration expires
- Jul 31, 2027
- Fiscal year end
- Jun 30
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 1 awards and $9,183,030 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004 Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50124C00051EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004 | Department of Health and Human Services | $9.2M | Sep 25, 2024 | Jun 30, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 31, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 26, 2018 |
| Entity start | May 30, 2017 |
Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| SANDRA K NELSON | Government business | Contact method not published | SAM registration | Not available |
| SHERWIN PEREZ | Alternate government business | Contact method not published | SAM registration | Not available |
| SANDRA K NELSON | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
About LUMOS DIAGNOSTICS, INC
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
2724 LOKER AVE W, CARLSBAD, California 92010, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit